Orca Bio announces Precision-T phase 3 study open and enrolling patients across US transplant centers
US-based Orca Bio, today announced Precision-T, its pivotal phase 3 study, is open, enrolling and…
August 3, 2022 - 2 minutes
US-based Orca Bio, today announced Precision-T, its pivotal phase 3 study, is open, enrolling and…
Treatment offered by Hansa Biopharma for the densensitization of highly sensitized adults prior to kidney…
Danish biotech Synklino has completed a Series A fundraising round that netted €29.8M ($31.8M). The…